ZIOPHARM ONCOLOGY INC's ticker is ZIOP and the CUSIP is 98973P101. A total of 131 filers reported holding ZIOPHARM ONCOLOGY INC in Q4 2017. The put-call ratio across all filers is 1.81 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $18,000 | -37.9% | 14,275 | +22.3% | 0.00% | – |
| Q3 2020 | $29,000 | -80.3% | 11,673 | -76.1% | 0.00% | -100.0% |
| Q2 2018 | $147,000 | -25.4% | 48,805 | -2.9% | 0.00% | 0.0% |
| Q1 2018 | $197,000 | -3.4% | 50,238 | +2.0% | 0.00% | 0.0% |
| Q4 2017 | $204,000 | -32.0% | 49,236 | +0.6% | 0.00% | -50.0% |
| Q3 2017 | $300,000 | +13.6% | 48,930 | +15.3% | 0.00% | 0.0% |
| Q2 2017 | $264,000 | +91.3% | 42,430 | +73.5% | 0.00% | +33.3% |
| Q3 2016 | $138,000 | +5.3% | 24,460 | +2.8% | 0.00% | 0.0% |
| Q2 2016 | $131,000 | -26.8% | 23,784 | -1.2% | 0.00% | -25.0% |
| Q1 2016 | $179,000 | +49.2% | 24,084 | +67.2% | 0.00% | +33.3% |
| Q4 2015 | $120,000 | -11.1% | 14,408 | -3.9% | 0.00% | -25.0% |
| Q3 2015 | $135,000 | – | 14,987 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Third Security, LLC | 17,815,708 | $47,033,000 | 2.93% |
| Essex Woodlands Management, Inc. | 2,764,908 | $7,130,000 | 2.60% |
| Belmont Global Advisors, Inc. | 973,000 | $2,569,000 | 2.01% |
| Belmont Global Advisors, Inc. | 135,700 | $358,000 | 0.28% |
| MSD Partners, L.P. | 2,750,000 | $7,260,000 | 0.22% |
| SFMG, LLC | 99,850 | $264,000 | 0.08% |
| Rotella Capital Management, Inc. | 11,090 | $29,000 | 0.03% |
| WESTPORT RESOURCES MANAGEMENT INC | 33,500 | $88,000 | 0.02% |
| SMITH ASSET MANAGEMENT GROUP LP | 236,590 | $625,000 | 0.02% |
| FRANKLIN STREET ADVISORS INC /NC | 41,150 | $109,000 | 0.02% |